Theratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024 - GlobeNewswire
| TH Stock | CAD 2.63 0.01 0.38% |
About 53% of Theratechnologies' investor base is interested to short. The analysis of the overall investor sentiment regarding Theratechnologies suggests that many traders are impartial. Theratechnologies' investing sentiment overview a quick insight into current market opportunities from investing in Theratechnologies. Many technical investors use Theratechnologies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Theratechnologies |
Theratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024 GlobeNewswire
Read at news.google.com
 |
Theratechnologies Fundamental Analysis
We analyze Theratechnologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theratechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theratechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Theratechnologies is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Theratechnologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theratechnologies stock to make a market-neutral strategy. Peer analysis of Theratechnologies could also be used in its relative valuation, which is a method of valuing Theratechnologies by comparing valuation metrics with similar companies.
Peers
Theratechnologies Related Equities
| DCM | Data Communications | 1.83 | ||||
| PBL | Pollard Banknote | 0.97 | ||||
| ELF-PG | E-L Financial | 0.85 | ||||
| ELF-PH | E L | 0.65 | ||||
| HFC | Hampton Financial | 0.00 | ||||
| RCI-A | Rogers Communications | 1.68 | ||||
| FTU-PB | US Financial | 1.76 |
Check out Theratechnologies Hype Analysis, Theratechnologies Correlation and Theratechnologies Performance. To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.